4//SEC Filing
PERRY MICHAEL S 4
Accession 0001250379-25-000003
CIK 0000879407other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 6:04 PM ET
Size
5.6 KB
Accession
0001250379-25-000003
Insider Transaction Report
Form 4
PERRY MICHAEL S
Director
Transactions
- Sale
Common Stock
2025-12-05$61.03/sh−16,250$991,738→ 115,240 total
Footnotes (2)
- [F1]The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $60.90 to $61.54, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
- [F2]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.
Documents
Issuer
ARROWHEAD PHARMACEUTICALS, INC.
CIK 0000879407
Entity typeother
Related Parties
1- filerCIK 0001250379
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 6:04 PM ET
- Size
- 5.6 KB